51
Participants
Start Date
May 31, 2007
Primary Completion Date
November 30, 2008
Study Completion Date
December 31, 2008
Artesunate
A 200 mg dose of orally administered artesunate at the beginning of a 48-hour clinical sampling period.
Kingasani Maternity Clinic, Kinshasa
Global Network for Women's and Children's Health Research
OTHER
Bill and Melinda Gates Foundation
OTHER
Fogarty International Center of the National Institute of Health
NIH
National Center for Complementary and Integrative Health (NCCIH)
NIH
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
National Cancer Institute (NCI)
NIH
RTI International
OTHER
University of North Carolina
OTHER
Kinshasa School of Public Health
OTHER
NICHD Global Network for Women's and Children's Health
NETWORK